Shilpa Medicare Unit IV, Jadcherla has cleared TGA, Australia GMP inspection
This inspection is the fourth major regulatory inspection (after Russia, Canada and Brazil), cleared by this site in the past two years
This inspection is the fourth major regulatory inspection (after Russia, Canada and Brazil), cleared by this site in the past two years
Venus Remedies' oncology wing has also secured marketing authorisation from Myanmar for another chemotherapy drug
NexCAR19 is an indigenously developed CD19 targeted CAR-T cell therapy
The launch of Elores in Ecuador is expected to open the doors for the entry of the novel antibiotic adjuvant entity in other important Latin American countries
Astria will assume full cost and responsibility for the global development and commercialization of the licensed therapeutic program for all indications
PFA technology is only marketed in Europe, and yet, it has been dominating the electrophysiology market by storm
Ayush Minister launched month long ayurveda celebration drive of Ministry of Ayush
Tagrisso is projected to be a pivotal contributor to AstraZeneca’s portfolio
Two-year partnership focused on advocacy, education, and raising awareness of stroke as a global healthcare challenge
Alignment of carbon-fiber can be controlled during the 3D printing process
Subscribe To Our Newsletter & Stay Updated